Bulgaria Discards Over 5 Million COVID-19 Vaccine Doses, Costing 145 Million Leva
Bulgaria has spent over 145 million leva on Covid-19 vaccines that were discarded between 2022 and 2024, according to Acting Minister of Health Galya Kondeva
The European Commission has granted approval for the Nuvaxovid XBB.1.5-adapted COVID-19 vaccine, a groundbreaking step in the fight against the ever-evolving pandemic. Developed by Novavax, this marks the first protein-based vaccine tailored to address the unique challenges posed by the autumn-winter season.
In a meticulous evaluation process, the European Medicines Agency (EMA) conducted a thorough assessment of the adapted vaccine. Following this evaluation, the European Commission fast-tracked its authorization to ensure that Member States have ample time to prepare for their upcoming autumn-winter vaccination campaigns.
Consistent with prior recommendations from the EMA and the European Center for Disease Prevention and Control (ECDC), adults and adolescents aged 12 and older, requiring vaccination, are strongly encouraged to receive a single dose. This guidance applies regardless of their previous COVID-19 vaccination history.
Novavax's achievement in adapting its COVID-19 vaccine to specifically target the SARS-CoV-2 Omicron strain XBB.1.5 aligns with the updated guidance provided by the ECDC and EMA regarding the composition of COVID-19 vaccines in response to new SARS-CoV-2 variants. This adapted vaccine is anticipated to broaden the scope of immunity, addressing both prevailing and emerging variants, as highlighted in the EC's official press release.
This authorization paves the way for a proactive response to the ongoing pandemic, ensuring that healthcare systems across Europe are well-equipped to tackle the challenges of the upcoming season.
Three new regions in Bulgaria have declared a flu epidemic following the increased spread of the virus
Vidin has become the second region in Bulgaria to declare a flu epidemic
Bulgaria has decided to temporarily halt the import of meat and animals from Brandenburg, Germany, following an outbreak of foot-and-mouth disease in the region
The flu season is intensifying, and by the end of this week, five regions in Bulgaria—Haskovo, Silistra, Pazardzhik, Vidin, and Yambol—are expected to be on the verge of a pre-epidemic situation
Flu cases are on the rise in Bulgaria, with certain regions expected to soon reach epidemic levels
Hospitals in major Bulgarian cities like Sofia, Pleven, Plovdiv, and Blagoevgrad have been found to be draining funds from the National Health Insurance Fund (NHIF)
Bulgaria's Perperikon: A European Counterpart to Peru's Machu Picchu
Bulgarians Among EU's Least Frequent Vacationers, Struggling with Affordability